Background: Sickle cell disorder (SCD), the commonest genetic (faulty gene inherited from both parents) condition in the UK, affects mainly underserved groups. Babies with SCD must start treatments soon after birth to prevent them becoming unwell. Stigma, fear and inequalities can make it difficult for parents to accept their child's diagnosis and access appropriate treatment and support. Aim: Develop strategies to improve support for parents during their child's first year of life following a SCD diagnosis to encourage early engagement with health services. Method: Comprises two stages: (i) Determine why parents choose to engage with support or not (ii) Use this information to co-design strategies to ensure greater accessibility of support for parents during their child's first year of life. Patient and Public Involvement: We are working with Sickle Cell Society and parents of children with SCD. Dissemination: Findings will be shared with support groups, charities, health professionals and academics.
Study Type
OBSERVATIONAL
Enrollment
30
Alder Hey Children's Hospital
Liverpool, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Support strategies for families with a child with SCD
Co-design strategies to ensure greater accessibility of support for parents during their child's first year of life following a SCD diagnosis
Time frame: June 2025
Existing support
Description of support strategies accessed nationally by parents during the first year following their child's SCD diagnosis
Time frame: July 2024
Parental reasons for accessing support
Reasons why parents choose to access support or not
Time frame: July 2024
Support priorities
priorities for improving accessibility to support for parents during their child's first year of life following a SCD diagnosis for the co-design groups
Time frame: Sept 2025
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.